Neurocognitive function in dopamine-β-hydroxylase deficiency

Neuropsychopharmacology

Volumn 36, Issue 8, 2011, Pages 1608-1619

  Jepma, Marieke ^a,d   Deinum, Jaap ^b   Asplund, Christopher L ^c   Rombouts, Serge A B ^a,d   Tamsma, Jouke T ^d   Tjeerdema, Nathanja ^d   Spapé, Michiel M ^e   Garland, Emily M ^f   Robertson, David ^f   Lenders, Jacques W M ^b,g   Nieuwenhuis, Sander ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VANDERBILT UNIVERSITY   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

brain; cognition; dopamine hydroxylase deficiency; DOPS; norepinephrine

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN SIZE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOPAMINE BETA MONOOXYGENASE DEFICIENCY; ELECTROENCEPHALOGRAM; FEMALE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PUPIL; RARE DISEASE; SYMPTOM; TASK PERFORMANCE; WHITE MATTER;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ATTENTION; AUTONOMIC NERVOUS SYSTEM DISEASES; COGNITION; COGNITION DISORDERS; DOPAMINE BETA-HYDROXYLASE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

EID: 79958816045     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.42     Document Type: Article

References (89)

1. Aghajanian GK, Cedarbaum JM, Wang RY (1977). Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res 136: 570-577. (Pubitemid 8228265)
2. Aston-Jones G, Cohen JD (2005). An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance (Review). Annu Rev Neurosci 28: 403-450. (Pubitemid 41098911)
3. Aston-Jones G, Foote SL, Bloom FE (1984). Anatomy and physiology of locus coeruleus neurons: functional implications. In: Ziegler M, Lake CR (eds). Norepinephrine. Frontiers of Clinical Neuroscience, Vol 2. Williams and Wilkins: Baltimore, MD. pp 92-116.
4. Aston-Jones G, Rajkowski J, Cohen J (2000). Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res 126: 165-182. (Pubitemid 35461288)
5. Beatty J, Wagoner BL (1978). Pupillometric signs of brain activation vary with level of cognitive processing. Science 199: 1216-1218. (Pubitemid 8311129)
6. Berridge CW, Waterhouse BD (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42: 33-84. (Pubitemid 36369264)
7. Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990). Dopamine-beta-hydroxylase deficiency in humans. Neurology 40: 370-373.
8. Biaggioni I, Robertson D (1987). Endogenous restoration of noradrenaline by precursor therapy in dopamine beta-hydro-xylase deficiency. Lancet 2: 1170-1172. (Pubitemid 17156597)
9. Bouret S, Sara SJ (2005). Network reset: a simplified overarching theory of locus coeruleus noradrenaline function (Review). Trends Neurosci 28: 574-582. (Pubitemid 41476687)
10. Buchner A, Rothermund K, Wentura D, Mehl B (2004). Valence of distractor words increases the effects of irrelevant speech on serial recall. Mem Cognit 32: 722-731. (Pubitemid 39391652)
11. Cahill L, McGaugh JL (1998). Mechanisms of emotional arousal and lasting declarative memory (Review). Trends Neurosci 21: 294-299. (Pubitemid 28293639)
12. Chamberlain SR, Müller U, Blackwell AD, Robbins TW, Sahakian BJ (2006). Noradrenergic modulation of working memory and emotional memory in humans (Review). Psychopharmacology (Berl) 188: 397-407. (Pubitemid 46758959)
13. Cheshire Jr WP, Dickson DW, Nahm KF, Kaufmann HC, Benarroch EE (2006). Dopamine beta-hydroxylase deficiency involves the central autonomic network. Acta Neuropathol 112: 227-229.
14. Cohen JD, Aston-Jones G, Gilzenrat MS (2004). A systems-level theory on attention and cognitive control: guided activation, adaptive gating, conflict monitoring, and exploitation versus exploration. In: Posner MI (ed). Cognitive Neuroscience of Attention. Guilford Press: New York. pp 71-90.
15. Colzato LS, Slagter HA, Spapé MM, Hommel B (2008). Blinks of the eye predict blinks of the mind. Neuropsychologia 46: 3179-3183.
16. Counts SE, Mufson EJ (2010). Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 113: 649-660.
17. Crawford JR, Garthwaite PH (2006). Comparing patients' predicted test scores from a regression equation with their obtained scores: a significance test and point estimate of abnormality with accompanying confidence limits. Neuropsychology 20: 259-271. (Pubitemid 43886861)
18. Crawford JR, Howell DC (1998). Comparing an individual's test score against norms derived from small samples. Clin Neurop-sychol 12: 482-486. (Pubitemid 29267969)
19. Cubells JF, Zabetian CP (2004). Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology (Berl) 174: 463-476. (Pubitemid 39119336)
20. Dayan P, Yu AJ (2006). Phasic norepinephrine: a neural interrupt signal for unexpected events. Network 17: 335-350. (Pubitemid 44905320)
21. De Martino B, Strange BA, Dolan RJ (2008). Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. Psychopharmacology (Berl) 197: 127-136.
22. Deinum J, Steenbergen-Spanjers GC, Jansen M, Boomsma F, Lenders JW, van Ittersum FJ et al (2004). DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41: e38.
23. Dolcos F, McCarthy G (2006). Brain systems mediating cognitive interference by emotional distraction. J Neurosci 26: 2072-2079.
24. Erez A, Li J, Geraghty MT, Ben-Shachar S, Cooper ML, Mensing DE et al (2010). Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiencyFcase report and review of the literature (Review). Am J Med Genet A 152A: 732-736.
25. Goldstein DS (2006). L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug (Review). Cardiovasc Drug Rev 24: 189-203. (Pubitemid 46435002)
26. Greene CM, Bellgrove MA, Gill M, Robertson IH (2009). Noradrenergic genotype predicts lapses in sustained attention. Neuropsychologia 47: 591-594.
27. Greenwood PM, Fossella JA, Parasuraman R (2005). Specificity of the effect of a nicotinic receptor polymorphism on individual differences in visuospatial attention. J Cogn Neurosci 17: 1611-1620. (Pubitemid 41510963)
28. Hess EH, Polt JM (1964). Pupil size in relation to mental activity during simple problem-solving. Science 143: 1190-1192.
29. Hobson JA, Lydic R, Bahdoyan HA (1986). Evolving concepts of sleep cycle generation: from brain centers to neuronal population. Behav Brain Sci 9: 371-448.
30. Hoffman BB, Taylor P (2001). Neurotransmission: the autonomic and somatic motor nervous system. In: Hardman JG, Limbird LE, Molinoff PB, Gilman AG (eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill: New York pp 115-153.
31. Hommel B, Akyürek EG (2005). Lag-1 sparing in the attentional blink: benefits and costs of integrating two events into a single episode. Q J Exp Psychol A 58: 1415-1433. (Pubitemid 43860707)
32. Ishikawa Y, Kato Y, Murakami Y, Inoue T, Koshiyama H, Imura H (1987). Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats. Proc Soc Exp Biol Med 184: 197-200. (Pubitemid 17022094)
33. Jouvet M (1969). Biogenic amines and the states of sleep. Science 163: 32-41.
34. Kahneman D (1973). Attention and Effort. Prentice-Hall: Englewood Cliffs, NJ.
35. Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT et al (2007). Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 28: 1206-1214. (Pubitemid 46810064)
36. Kato T, Karai N, Katsuyama M, Nakamura M, Katsube J Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa. Biochem Pharmacol, (1987a) 36: 3051-3057. (Pubitemid 17142314)
37. Kato T, Katsuyama M, Karai N, Nakamura M, Katsube J Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice. Pharmacol Biochem Behav, (1987b) 26: 407-411. (Pubitemid 17038127)
38. Liu J, Kiehl KA, Pearlson G, Perrone-Bizzozero NI, Eichele T, Calhoun VD (2009). Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. Neuroimage 46: 809-816.
39. Maclean MH, Arnell KM (2010). Personality predicts temporal attention costs in the attentional blink paradigm. Psychon Bull Rev 17: 556-562.
40. Madrigal JL, Kalinin S, Richardson JC, Feinstein DL (2007). Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J Neurochem 103: 2092-2101. (Pubitemid 350126619)
41. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL (2009). Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci 29: 263-267.
42. Man in 't Veld AJ, Boomsma F, Moleman P, Schalekamp MA Congenital dopamine-beta hydroxylase deficiency. A novel orthostatic syndrome. Lancet, (1987a) 1: 183-188. (Pubitemid 17008191)
43. Man in 't Veld AJ, Boomsma F, van den Meiracker AH, Schalekamp MA Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopa-mine-beta-hydroxylase deficiency. Lancet, (1987b) 2: 1172-1175. (Pubitemid 17156598)
44. Marino MD, Bourdélat-Parks BN, Cameron Liles L, Weinshenker D (2005). Genetic reduction of noradrenergic function alters social memory and reduces aggression in mice. Behav Brain Res 161: 197-203. (Pubitemid 40732401)
45. Martens S, Wyble B (2010). The attentional blink: past, present, and future of a blind spot in perceptual awareness (Review). Neurosci Biobehav Rev 34: 947-957.
46. Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S et al (1990). Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrena-line from dopamine because of a deficiency of dopamine beta hydroxylase. Q J Med 75: 617-633. (Pubitemid 20214395)
47. Murchison CF, Zhang XY, Zhang WP, Ouyang M, Lee A, Thomas SA (2004). A distinct role for norepinephrine in memory retrieval. Cell 117: 131-143. (Pubitemid 38469904)
48. Nieuwenhuis S, Gilzenrat MS, Holmes BD, Cohen JD The role of the locus coeruleus in mediating the attentional blink: a neurocompu-tational theory. J Exp Psychol Gen, (2005a) 134: 291-307. (Pubitemid 41323150)
49. Nieuwenhuis S, Aston-Jones G, Cohen JD Decision making, the P3, and the locus coeruleus norepinephrine system (Review). Psychol Bull, (2005b) 131: 510-532. (Pubitemid 41168494)
50. Nieuwenhuis S, van Nieuwpoort IC, Veltman DJ, Drent ML (2007). Effects of the noradrenergic agonist clonidine on temporal and spatial attention. Psychopharmacology (Berl) 193: 261-269. (Pubitemid 47025021)
51. Oei NY, Tollenaar MS, Elzinga BM, Spinhoven P (2010). Propranolol reduces emotional distraction in working memory: a partial mediating role of propranolol-induced cortisol increases? Neurobiol Learn Mem 93: 388-395.
52. Oei NY, Tollenaar MS, Spinhoven P, Elzinga BM (2009). Hydrocortisone reduces emotional distracter interference in working memory. Psychoneuroendocrinology 34: 1284-1293.
53. Parasuraman R, Greenwood PM, Kumar R, Fossella J (2005). Beyond heritability: neurotransmitter genes differentially modulate visuospatial attention and working memory. Psychol Sci 16: 200-207. (Pubitemid 40451209)
54. Peeters FPML, Ponds RWHM, Vermeeren MTG (1996). Affectivity and self-report of depression and anxiety (Dutch). Tijdschr Psych 38: 240-250. (Pubitemid 26101747)
55. Pineda JA, Foote SL, Neville HJ (1989). Effects of locus coeruleus lesions on auditory, long-latency, event-related potentials in monkey. J Neurosci 9: 81-93. (Pubitemid 19057176)
56. Raven JC, Court JH, Raven J (1988). Manual for Raven's Progressive Matrices and Vocabulary Scales: Section 3 Standard Progressive Matrices. Lewis: London.
57. Raymond JE, Shapiro KL, Arnell KM (1992). Temporary suppression of visual processing in an RSVP task: an attentional blink? J Exp Psychol Hum Percept Perform 18: 849-860.
58. Ressler KJ, Nemeroff CB (2001). Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr 6: 663-666.
59. Robbins TW (1997). Arousal systems and attentional processes (Review). Biol Psychol 45: 57-71. (Pubitemid 27110537)
60. Robbins TW, Arnsten AF (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation (Review). Annu Rev Neurosci 32: 267-287.
61. Robertson D, Garland EM (2010). Dopamine Beta-Hydroxylase Deficiency. GeneReviews http://www.ncbi.nlm.nih.gov/books/ NBK1474/.
62. Robertson D, Goldberg MR, Onrot J, Hollister AS, Wiley R, Thompson Jr JG et al (1986). Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N Engl J Med 314: 1494-1497. (Pubitemid 16114667)
63. Robertson D, Haile V, Perry SE, Robertson RM, Phillips III JA, Biaggioni I (1991). Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation. Hypertension 18: 1-8.
64. Roman T, Schmitz M, Polanczyk GV, Eizirik M, Rohde LA, Hutz MH (2002). Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am J Med Genet 114: 154-158. (Pubitemid 34160466)
65. Roth WT, Dorato KH, Kopell BS (1984). Intensity and task effects on evoked physiological responses to noise bursts. Psychophy-siology 21: 466-481. (Pubitemid 14080918)
66. Sara SJ (2009). The locus coeruleus and noradrenergic modulation of cognition (Review). Nat Rev Neurosci 10: 211-223.
67. Semba J, Takahashi R (1985). The effects of L-threo-dihydrox- yphenylserine on norepinephrine metabolism in rat brain. Psychiatry Res 15: 319-326. (Pubitemid 15015250)
68. Servan-Schreiber D, Printz H, Cohen JD (1990). A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science 249: 892-895.
69. Shapiro KL, Caldwell J, Sorensen RE (1997). Personal names and the attentional blink: a visual 'cocktail party' effect. J Exp Psychol Hum Percept Perform 23: 504-514. (Pubitemid 127458888)
70. Siever LJ, Davis KL (1985). Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 142: 1017-1031. (Pubitemid 16250774)
71. Skinbjerg M, Seneca N, Liow JS, Hong J, Weinshenker D, Pike VW et al (2010). Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand binding. Synapse 64: 699-703.
72. Smith SA, Smith SE (1999). Bilateral Horner's syndrome: detection and occurrence. J Neurol Neurosurg Psychiatry 66: 48-51. (Pubitemid 29101486)
73. Strange BA, Dolan RJ (2004). Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci USA 101: 11454-11458. (Pubitemid 39038368)
74. Strange BA, Hurlemann R, Dolan RJ (2003). An emotion-induced retrograde amnesia in humans is amygdala- and beta-adrener-gic-dependent. Proc Natl Acad Sci USA 100: 13626-13631. (Pubitemid 37448564)
75. Sutton S, Braren M, Zubin J, John ER (1965). Evoked-potential correlates of stimulus uncertainty. Science 150: 1187-1188.
76. Thomas SA, Marck BT, Palmiter RD, Matsumoto AM (1998). Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70: 2468-2476. (Pubitemid 28252372)
77. Thomas SA, Matsumoto AM, Palmiter RD (1995). Noradrenaline is essential for mouse fetal development. Nature 374: 643-646.
78. Thomas SA, Palmiter RD Disruption of the dopamine beta-hydroxylase gene in mice suggests roles for norepinephrine in motor function, learning, and memory. Behav Neurosci, (1997a) 111: 579-589. (Pubitemid 27251327)
79. Thomas SA, Palmiter RD Impaired maternal behavior in mice lacking norepinephrine and epinephrine. Cell, (1997b) 91: 583-592. (Pubitemid 27513650)
80. Thompson JM, O'Callaghan CJ, Kingwell BA, Lambert GW, Jennings GL, Esler MD (1995). Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. J Auton Nerv Syst 55: 198-206.
81. Timmers HJ, Deinum J, Wevers RA, Lenders JW (2004). Congenital dopamine-beta-hydroxylase deficiency in humans (Review). Ann NY Acad Sci 1018: 520-523. (Pubitemid 38951448)
82. Tulen JH, Man in 't Veld AJ, Dzoljic MR, Mechelse K, Moleman P (1991). Sleeping with and without norepinephrine: effects of metoclopramide and D,L-threo-3,4-dihydroxyphenylserine on sleep in dopamine beta-hydroxylase deficiency. Sleep 14: 32-38.
83. Tulen JH, Man in't Veld AJ, Mechelse K, Boomsma F (1990). Sleep patterns in congenital dopamine beta-hydroxylase deficiency. J Neurol 237: 98-102. (Pubitemid 20152078)
84. Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999). The role of locus coeruleus in the regulation of cognitive performance. Science 283: 549-554.
85. Warren CM, Breuer AT, Kantner J, Fiset D, Blais C, Masson ME (2009). Target-distractor interference in the attentional blink implicates the locus coeruleus-norepinephrine system. Psychon Bull Rev 16: 1106-1111.
86. Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063-1070.
87. Wechsler D. Weschsler Adult Intelligence Scale-III. The Psychological Corporation: San Antonio, TX; (1997).
88. Zhang W, Klimek V, Farley JT, Zhu MY, Ordway GA (1999). Alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine. J Pharmacol Exp Ther 289: 1286-1292. (Pubitemid 29246656)
89. Zhang WP, Ouyang M, Thomas SA (2004). Potency of catechola-mines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors. Neuropharmacology 47: 438-449. (Pubitemid 38953235)